Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration. (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration. (Articolo in rivista) (literal)

Anno

• 2008-01-01T00:00:00+01:00 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi

• 10.1016/j.ejphar.2008.08.020 (literal)

Alternative label

• Marchese G a,b; Sanna A b; Casu G b; Casti P b; Spada GP b; Ruiu S a,b; Pani L a,b (2008)
  Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration.
  in European journal of pharmacology; Editore: Elsevier, Oxford (Regno Unito)
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Marchese G a,b; Sanna A b; Casu G b; Casti P b; Spada GP b; Ruiu S a,b; Pani L a,b (literal)

Pagina inizio

• 16 (literal)

Pagina fine

• 20 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url

• http://www.elsevier.com/locate/ejphar (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 598 (literal)

Rivista

• European journal of pharmacology (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

• 1-3 (literal)

Note

• ISI Web of Science (WOS) (literal)
• PubMe (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• a C.N.R., Institute of Biomedical Technology, Sect. Cagliari, Technological Park of Sardinia\"Sardegna Ricerche\", Pula, Cagliari, Italy b Neuroscienze-Pharmaness S.c.a r.l., Technological Park of Sardinia\"Sardegna Ricerche\", Pula, Cagliari, Italy (literal)

Titolo

• Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration. (literal)

Abstract

• It was previously shown that haloperidol, but not clozapine, induced intense rat catalepsy when co-administered with delta-9-tetrahydrocannabinol. The present study investigated whether similar alterations could be observed on striatal c-Fos immunoreactivity after administration of the same drug combinations. Western Blot and immunocytochemistry stereological analyses indicated that delta-9-tetrahydrocannabinol (0.5 mg/kg) increased striatal c-Fos immunoreactivity induced by haloperidol (0.1 mg/kg). Conversely, no significant alterations of striatal c-Fos immunoreactivity were observed after injections of clozapine (10 mg/kg)+vehicle, clozapine+delta-9-tetrahydrocannabinol or vehicle+delta-9-tetrahydrocannabinol. The present results indicate that the behavioral effects induced by delta-9-tetrahydrocannabinol in haloperidol- and clozapine-treated rats are associated with different striatal c-Fos expressions. (literal)

Editore

• Editore: Elsevier (Editore)

Prodotto di

• Drug design, drug delivery e valutazione preclinica di nuove entità chimiche. (ME.P06.020.001) (Modulo)

Autore CNR

• LUCA PANI (Persona)
• GIORGIO MARCHESE (Persona)
• STEFANIA RUIU (Unità di personale interno)

Insieme di parole chiave

• Keywords of "Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration." (Insieme di parole chiave)

Incoming links:

Autore CNR di

• GIORGIO MARCHESE (Persona)
• STEFANIA RUIU (Unità di personale interno)
• LUCA PANI (Persona)

Prodotto

• Drug design, drug delivery e valutazione preclinica di nuove entità chimiche. (ME.P06.020.001) (Modulo)

Editore di

• Editore: Elsevier (Editore)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• European journal of pharmacology (Rivista)

Insieme di parole chiave di

• Keywords of "Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration." (Insieme di parole chiave)